Artelo Biosciences, Inc. (ARTL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.87M |
| Enterprise Value | 2.97M |
| P/E Ratio | -0.13 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.14 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.08 |
| Return On Equity | -16.02 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -12.54M |
| Net Income | -12.88M |
| Diluted EPS | -5.47 |
| Total Cash | 10.27M |
| Total Cash/Share | 13.9 |
| Total Debt | 755,000 |
| Total Debt/Equity | 0.11 |
| Current Ratio | 1.79 |
| Book Value Per Share | 9.03 |
| 52-Week Change | -78.91 |
| 52-Week High | 85.8 |
| 52-Week Low | 1.19 |
| Moving Average 50 Days | 2.67 |
| Moving Average 200 Days | 6.38 |
| Average Volume | 3.27M |
| Shares Outstanding | 2.33M |
| % Held by Institutions | 6.17 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
| Last Split Date | March 10, 2026 |